Patient Reactions to Confidentiality, Liability, and Financial Aspects of Informed Consent in Cardiology Research

被引:2
作者
Fortune-Greeley, Alice K.
Hardy, N. Chantelle
Lin, Li
Friedman, Joelle Y.
Lawlor, Janice S. [6 ]
Muhlbaier, Lawrence H. [2 ,3 ]
Hall, Mark A. [7 ]
Schulman, Kevin A. [4 ]
Sugarman, Jeremy [8 ,9 ]
Weinfurt, Kevin P. [1 ,5 ]
机构
[1] Duke Univ, Sch Med, Ctr Clin & Genet Econ, Duke Clin Res Inst, Durham, NC 27715 USA
[2] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC 27715 USA
[3] Duke Univ, Sch Med, Dept Surg, Durham, NC 27715 USA
[4] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA
[5] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27715 USA
[6] Wake Forest Univ, Bowman Gray Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC USA
[7] Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA
[8] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA
[9] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
来源
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2010年 / 3卷 / 02期
关键词
informed consent; biomedical research; conflict of interest; confidentiality; CONFLICTS-OF-INTEREST; POTENTIAL RESEARCH PARTICIPANTS; HIPAA PRIVACY RULE; RESEARCH-RELATED INJURIES; CLINICAL-RESEARCH; TRIAL; COMPENSATION; QUALITY; IMPACT; ENROLLMENT;
D O I
10.1161/CIRCOUTCOMES.109.849273
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Although the informed consent process is supposed to help potential research participants make informed and voluntary decisions about participating in research, little is known about how participants react to language in the informed consent document and whether their reactions are related to their willingness to enroll in clinical trials. We examined the relationship between patients' reactions to standard informed consent language and their willingness to participate in a hypothetical clinical trial. Methods and Results-We simulated the consent process for a hypothetical cardiology clinical trial with 470 patients in an outpatient cardiovascular medicine clinic at a large academic medical center. We analyzed the spontaneous comments and questions that participants made during the interviews about each section of the informed consent document. Few participants made positive comments. Participants made the most negative comments about the sections on risks, study purpose or protocol, and payment for injury. Having a negative reaction to any section was associated with a lower likelihood of participating in the clinical trial. Using a multivariable model, we found that negative reactions in the patient rights, financial disclosure, and confidentiality sections predicted willingness to participate (P<0.001). Conclusions-Recognizing elements of informed consent that elicit questions and concerns from potential research participants may help investigators design clinical research trials and model language in a way that reduces concerns or increases participant understanding, thereby enhancing informed consent for research. (Circ Cardiovasc Qual Outcomes. 2010; 3: 151-158.)
引用
收藏
页码:151 / U90
页数:17
相关论文
共 38 条
[1]  
AAMC Task Force on Financial Conflicts of Interest in Clinical Research, 2003, Acad Med, V78, P225
[2]  
[Anonymous], 1986, A History and Theory of Informed Consent Internet
[3]  
[Anonymous], 2004, Federal Registry, V69, P26393
[4]  
[Anonymous], 2006, J BIOGEOGR, DOI DOI 10.1111/j.1365-2699.2006.01466.x
[5]   Potential impact of the HIPAA privacy rule on data collection in a registry of patients with acute coronary syndrome [J].
Armstrong, D ;
Kline-Rogers, E ;
Jani, SM ;
Goldman, EB ;
Fang, JM ;
Mukherjee, D ;
Nallamothu, BK ;
Eagle, KA .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (10) :1125-1129
[6]  
Beh Hazel, 2005, IRB, V27, P11, DOI 10.2307/3564074
[7]   COMPENSATING INJURED RESEARCH SUBJECTS .1. MORAL ARGUMENT [J].
CHILDRESS, JF .
HASTINGS CENTER REPORT, 1976, 6 (06) :21-27
[8]   Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: A study of the eastern cooperative oncology group [J].
Coyne, CA ;
Xu, RH ;
Raich, P ;
Plomer, K ;
Dignan, M ;
Wenzel, LB ;
Fairclough, D ;
Habermann, T ;
Schnell, L ;
Quella, S ;
Cella, D .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) :836-842
[9]  
Danforth W, 2003, ACAD MED, V78, P237
[10]  
DHHS, 2002, FED REG 0814, V67, P53181